April 22, 2018 1:23 PM ET

Company Overview of Karolinska Institutet

Company Overview

Karolinska Institutet is a Swedish university, which specializes in medicine. Several companies in the field of medicine and biotechnology have been founded as a result of the university's research programmes. As a result, Karolinska Institutet cooperates closely with the private sector and has created an investment arm (Karolinska Investment Fund) in order to enhance its scientists' innovations. Founded in 1810, the company is headquartered in Stockholm.

Stockholm,  SE-171-77

Sweden

Founded in 1810

Phone:

46 8 728 64 00

Fax:

46 8 31 11 01

Key Executives for Karolinska Institutet

Vice President
Professor of Environmental Toxicology
Professor of Pharmacology
Professor of Neurobiology
Compensation as of Fiscal Year 2017.

Karolinska Institutet Key Developments

Karolinska Institutet Presents at 13th World Stem Cell Summit, Jan-22-2018 through Jan-26-2018

Karolinska Institutet Presents at 13th World Stem Cell Summit, Jan-22-2018 through Jan-26-2018. Venue: Hyatt Regency Miami, Miami, Florida, United States. Presentation Date & Speakers: Jan-23-2018, Evren Alici, CEO; Director, Cell & Gene Therapy Centre – Vycellix. Jan-24-2018, Outi Hovatta, Obstetrics and Gynaecology.

LIDDS Enters Research Collaboration with Department of Laboratory Medicine at Karolinska Institute

LIDDS has entered a research collaboration with the Department of Laboratory Medicine at Karolinska Institute, Sweden. The collaboration regards fundamental preclinical studies on formulations based on the NanoZolid technology, as well as access to risk laboratories for formulation development. LIDDS broadens its R&D activities to develop novel NanoZolid formulations for local tumor therapy by establishing a collaboration with Professor Mustapha Hassan and Dr. Ying Zhau at the Department of Laboratory Medicine (LABMED) at Karolinska Institute in Huddinge. The collaboration includes fundamental preclinical studies and gives access to risk laboratories for formulation development with hazardous substances. Within the frame of the collaboration, novel NanoZolid formulations will be investigated prior to entering the clinical phase.

Karolinska Institutet Presents at Society for Neuroscience Annual Meeting, Nov-14-2017 11:30 AM

Karolinska Institutet Presents at Society for Neuroscience Annual Meeting, Nov-14-2017 11:30 AM. Venue: Washington, District Of Columbia, United States. Speakers: Ole Kiehn.

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Karolinska Institutet, please visit www.ki.se. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.